Ajanta Pharma Limited

NSE: AJANTPHARM

Healthcare Healthcare

₹2,968.8

-0.26%EOD · 8 Jun

Ajanta Pharma Limited is a listed Healthcare company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹37,091 Cr

52W Range

₹3315 / ₹2330

Volume

110K

34.0% delivery

1Y Return

+12.7%

P/E Ratio

35.2

P/B Ratio

8.2

ROE

25.4%

Debt / Equity

5.75

Peers in Healthcare

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Ajanta Pharma Limited(this stock)	₹2,968.8	₹37,091 Cr	35.2	8.2	25.4%	1.88%
Divi's Laboratories LimitedDIVISLAB	₹6,521	₹1.73 L Cr	68.5	10.5	16.2%	0.45%
Torrent Pharmaceuticals LimitedTORNTPHARM	₹4,410.4	₹1.49 L Cr	69.0	17.7	17.0%	0.86%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	₹8,358.5	₹1.20 L Cr	61.4	12.6	21.5%	0.24%
Zydus Lifesciences LimitedZYDUSLIFE	₹1,087.6	₹1.09 L Cr	21.7	4.3	18.3%	0.09%
Max Healthcare Institute LimitedMAXHEALTH	₹1,007.45	₹98,049 Cr	66.2	8.8	14.3%	0.15%
Mankind Pharma LimitedMANKIND	₹2,357.4	₹97,339 Cr	50.5	6.3	12.4%	0.09%
Aurobindo Pharma LimitedAUROPHARMA	₹1,451.8	₹83,533 Cr	24.2	2.2	9.9%	0.27%
Laurus Labs LimitedLAURUSLABS	₹1,404.7	₹75,889 Cr	92.6	14.7	17.7%	0.17%

Technical Indicators

Full analysis · objective math, not advice

Returns

-0.3%

+1.9%

-8.9%

-0.2%

+11.7%

+12.7%

Weinstein Stage

Stage 2 — Advancing (uptrend)

RSI (14)

27 Oversold

Trend Template

6/7strong

Moving Averages (price vs MA)

20-DMA

₹3046

below

50-DMA

₹2951

above

150-DMA

₹2825

above

200-DMA

₹2740

above

From 52W High

-10.4%

From 52W Low

+27.4%

Support (20D)

₹2850

Resistance (20D)

₹3315

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.